Medtronic PLC vs VanEck Semiconductor ETF — how do they compare? Medtronic PLC trades at $82.63 (market cap $106.61B), while VanEck Semiconductor ETF trades at $583.77. The key difference: Medtronic PLC pays a 3.46% dividend while VanEck Semiconductor ETF pays none, and VanEck Semiconductor ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| MDT | SMH | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | — |
52-Week High | $105.35 | $668.91 |
52-Week Low | $73.75 | $283.95 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $82.35, down 1.02% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS expected at $1.39. Revenue grew to $33.54B in 2025, with a net income margin of 13.2%. Recent news highlights the acquisition of SPR and the launch of AI-powered surgical technology, signaling innovation-driven growth.
The outlook for MDT is positive, supported by analyst consensus with a $97.50 price target and 58% buy ratings. Key opportunities include robust cash flow and dividend stability, while risks involve rising debt levels and competitive pressures in medtech. The stock presents a value proposition with a P/E of 22.33, trading below the consensus target.
SMH trades at $584.08, up 5.08% today amid volatile semiconductor sector conditions. The ETF shows bearish technical signals with moving averages indicating selling pressure, though RSI levels suggest potential oversold conditions. Recent institutional buying by firms like Empirical Wealth Management and Assetmark Inc. contrasts with mixed news flow including China's potential AI chip export controls and concerns about AI trade rotation. The fund remains concentrated in top semiconductor names with strong AI exposure.
Outlook remains cautious as semiconductor stocks face sector rotation pressures despite strong AI demand fundamentals. Key risks include geopolitical tensions, potential capex slowdowns, and valuation concerns after the 2026 rally. The current technical setup suggests near-term consolidation between support at $538-$553 and resistance at $569-$584 levels.
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →